SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is trending after the closing of its AI licensing partnership in Africa, establishing Skye Africa Intelligence. The community is actively discussing the strong potential for a short squeeze, citing the stock's low float, high cost-to-borrow, and increasing short interest.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending after its HLP004 Phase 2 results for Generalized Anxiety Disorder led to a significant stock sell-off, prompting community discussion over the data's efficacy nuances and ironic jokes about the company's ticker symbol, "$HELP." Investors are debating if the drop is an overreaction typical of biotech or justified by data concerns, with many viewing it as a buying opportunity.

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc

Nutex Health is trending following its Q4 earnings, which presented a revenue miss that management clarified with adjustments showing substantial annual growth and robust cash flow, alongside a new $25M share repurchase program. The community is actively debating these financial nuances and largely dismissing a new short report from Capybara Research as an unsubstantiated effort by short sellers to manipulate sentiment.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending after reporting strong quarterly results and significantly raising its future revenue guidance, propelled by robust AI and data center demand. This has sparked widespread optimism among bulls, who anticipate further upside and analyst upgrades, although some in the community express caution regarding the sustainability of the rally.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending following its earnings report, which, despite mixed profitability, triggered positive sentiment in Hong Kong due to a reaffirmed dividend and share buyback, amid ongoing community debate about the company's deep value within a recovering Chinese tech sector.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending after a mixed earnings report that included a revenue beat, an EPS miss, and the announcement of CEO Doug Ingram's retirement, prompting community discussions about potential M&A and future leadership. Investors are also keenly anticipating upcoming Q1 data readouts for key pipeline assets like DM1 and FSHD, alongside ongoing debate over the impact of a potentially more streamlined regulatory environment for rare disease gene therapies on the company's valuation.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery is trending amid an intense bidding war, as its board deemed Paramount Skydance's revised offer "superior," prompting a four-day window for Netflix to submit a counter-bid. The community is heavily discussing the significant debt burden this acquisition could place on Paramount Skydance, contrasting it with Netflix's potential to walk away with a substantial breakup fee and its impact on the future streaming landscape.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is witnessing a rapid rebound, with its core holdings Samsung and SK Hynix leading a significant surge in the KOSPI index. Community discussion highlights that strong fundamentals in the AI-driven memory chip supercycle are overshadowing recent geopolitical concerns, positioning South Korean tech as an attractive and undervalued opportunity.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne (TER) initially rallied significantly on a strong Q4 earnings beat and optimistic guidance, propelled by surging AI-driven demand in its semiconductor test and robotics divisions. However, the market is now reacting to cautious commentary during the post-earnings conference call, leading to a notable pullback despite the strong underlying AI tailwinds that continue to fuel community discussion.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending amidst sharp investor debate following its recent earnings report and reiterated conservative 2026 guidance, which many view as significantly undervaluing its hyper-growth revenue and strong pipeline. Despite widespread frustration over persistent stock price declines, the initiation of a $75 million share buyback and upcoming catalysts like Rezzayo Phase 3 data are key talking points, fueling arguments about the company's true value and future potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FOLDShares of Amicus Therapeutics (FOLD) rose by 14% on Thursday after the company made a deal with Teva Pharmaceuticals to settle their patent dispute. Teva wanted to sell a generic version of Amicus' drug GALAFOLD before its patent expired.&nbsp;According to the agreement, Teva can start selling the generic version in the U.S. in 2037, if it gets approved by the FDA. Both companies have agreed to drop all legal cases related to this issue.BofA raised its price target for Amicus shares to $15 from $13 while maintaining its ‘Buy’ rating on the stock. BofA sees this as a positive step since other similar legal cases with Aurobindo and Lupin are still unresolved. The settlement also eases worries that investors had about the ongoing legal risks.<figure class="image"><a href="https://stocktwits.com/symbol/FOLD"><img style="aspect-ratio:641/141;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_232351_f081877e12.png" alt="Screenshot 2024-10-17 232351.png" width="641" height="141"></a><figcaption>Amicus Therapeutics Inc’s sentiment meter as of 1:50 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits has flipped to ‘extremely bullish’ (97/100) from ‘extremely bearish’ just a day ago.&nbsp;PIXYShares of ShiftPixy Inc (PIXY) jumped 78% on Thursday after the national staffing enterprise&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pixy-stock-jumps-after-acquisition-of-turboscale/cJ2bf0eRIJ">announced</a> the acquisition of TurboScale, an AI technology company specializing in scalable GPU cloud infrastructure and AI model deployment.&nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/PIXY"><img style="aspect-ratio:643/139;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_232837_c9a1f738e9.png" alt="Screenshot 2024-10-17 232837.png" width="643" height="139"></a><figcaption>ShiftPixy Inc’s sentiment meter as of 1:55 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>PIXY became the top trending ticker on Stocktwits on Thursday morning after the announcement. Retail sentiment around the stock is more ‘extremely bullish’ (95/100) from ‘bearish’ a day ago.&nbsp;BXBlackstone shares soared 7% on Thursday after the firm posted third-quarter earnings that surpassed Wall Street expectations.Wells Fargo has maintained its ‘Overweight’ rating on the stock and set a price target of $169. The brokerage noted that while Blackstone's Q3 earnings per share (EPS) were better than expected, the improvements were of "fairly low quality," mainly due to favorable changes in the tax rate and other less reliable factors.&nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/BX"><img style="aspect-ratio:643/141;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_233818_5961473307.png" alt="Screenshot 2024-10-17 233818.png" width="643" height="141"></a><figcaption>Blackstone Inc’s sentiment meter as of 1:50 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits has shifted to ‘extremely bullish’ (94/100) from ‘bearish’ a day ago.&nbsp;For updates and corrections email newsroom@stocktwits.com.Read more:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsmc-stock-surges-pre-market-on-quarterly-profit-jump/cJ2bJ8gRIE">TSMC Stock Surges Pre-Market, Lifting Apple and Nvidia After Quarterly Profit Jump – Retail Rejoices</a>

Amicus Therapeutics, ShiftPixy, and Blackstone experience significant stock surges as retail sentiment turns extremely bullish after key developments.

Amicus Therapeutics, ShiftPixt, Blackstone: Retail Investors Turn Most Bullish On These 3 Stocks

Amicus Therapeutics soared after resolving a patent dispute, while ShiftPixy jumped on its AI acquisition. Blackstone gained following a strong earnings report.

Equity

Shares of Florida-based national staffing enterprise ShiftPixy Inc (PIXY) jumped 150% on Thursday after the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20241017922928/en/ShiftPixy-Inc.-Announces-Acquisition-of-TurboScale">announced</a> the acquisition of TurboScale, an AI technology company specializing in scalable GPU cloud infrastructure and AI model deployment.PIXY became the top trending ticker on Stocktwits on Thursday morning after the announcement. The deal size amounts to $150 million, which was structured with $75 million in stock and $75 million in debt.TurboScale CEO Chandler Song said ShiftPixy provides a perfect platform for many use cases of AI to blossom. “The two companies plan to build training and inference infrastructure for vertical AIs that include HR, Sales, Customer Services, and many more,” he said.ShiftPixy said that the acquisition will allow the firm to introduce enhanced AI-powered features, such as real-time predictive analytics and machine learning-driven automation, to streamline workforce management.“By integrating TurboScale’s advanced GPU cloud and AI technology, ShiftPixy will enhance its ability to optimize staffing efficiency, improve labor forecasting, and offer advanced AI-driven workforce solutions for clients across multiple industries,” the firm said.According to ShiftPixy, TurboScale’s platform offers cost-efficient, highly configurable virtual machines and private cloud solutions, tailored to meet the diverse needs of enterprises, from small experiments to large-scale AI deployments.Following the announcement, retail sentiment on Stocktwits jumped into the ‘extremely bullish’ territory (94/100), accompanied by 'extremely high' message volumes.<figure class="image"><a href="https://stocktwits.com/symbol/PIXY"><img style="aspect-ratio:1648/466;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_at_9_36_19_AM_915334dd1c.png" alt="PIXY sentiment meter as of 9:36 a.m. ET on Oct. 17, 2024 | Source: Stocktwits" width="1648" height="466"></a><figcaption>PIXY sentiment meter as of 9:36 a.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Shares of PIXY have recorded losses of over 83% on a year-to-date basis.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/blackstone-q3-tops-estimates/cJ2b90ARII">Blackstone Beats Q3 Estimates, AUM Reaches Record $1.11T: Stock Rises, But Retail Caution Lingers</a>For updates and corrections email newsroom@stocktwits.com

PIXY became the top trending ticker on Stocktwits on Thursday morning after the deal announcement | Representative Image Source: Pexels

PIXY Stock Jumps After Acquisition Of TurboScale: Retail Turns Extremely Bullish

The deal size amounts to $150 million, which was structured with $75 million in stock and $75 million in debt.

ShiftPixy, Inc. engages in the provision of human capital services. Its services include employment tax processing, human resources and employment compliance, employment related insurance, and employment administrative services solutions. The company was founded by Scott W. Absher and J. Stephen Holmes on June 3, 2015 and is headquartered in Miami, FL.

PIXY
ShiftPixy Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PIXY News

PIXYShiftPixy Inc